Beaton Management Company’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,741
Closed -$308K 116
2020
Q1
$308K Hold
1,741
0.31% 81
2019
Q4
$333K Hold
1,741
0.26% 89
2019
Q3
$293K Buy
1,741
+50
+3% +$8.15K 0.24% 97
2019
Q2
$283K Sell
1,691
-75
-4% -$10.4K 0.23% 95
2019
Q1
$259K Hold
1,766
0.22% 102
2018
Q4
$236K Sell
1,766
-125
-7% -$20.5K 0.23% 99
2018
Q3
$361K Buy
1,891
+100
+6% +$18.4K 0.3% 88
2018
Q2
$299K Hold
1,791
0.27% 95
2018
Q1
$301K Buy
1,791
+150
+9% +$25.2K 0.28% 94
2017
Q4
$268K Sell
1,641
-200
-11% -$35.9K 0.24% 98
2017
Q3
$377K Hold
1,841
0.36% 77
2017
Q2
$448K Buy
+1,841
New +$433K 0.44% 65

Other funds holding AGN

Beaton Management Company's AGN Position: Q2 2020 in Review

Beaton Management Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,741 shares — an estimated $308K sold.

Beaton Management Company first reported a position in AGN in Q2 2017 and held it in 12 quarters. The position peaked at $448K in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Beaton Management Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Beaton Management Company sold 1,741 Allergan plc shares in Q2 2020, an estimated $308K.
  • Beaton Management Company first reported a position in Allergan plc in Q2 2017 and held it in 12 quarters.
  • Beaton Management Company's Allergan plc position peaked at $448K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Beaton Management Company's 13F filing for Q2 2020, filed 14 Aug 2020.